Endpoints News 生物医药· Elizabeth Cairns·· 29 天前AI 评分13
Roche talks up Phase 3 success rate as it unveils pipeline cuts
Roche talks up Phase 3 success rate as it unveils pipeline cuts
AI 导读
Roche talks up Phase 3 success rate as it unveils pipeline cuts.
正文
Where other European pharmas — notably Novartis, Novo and AstraZeneca — have suffered huge late-stage clinical failures this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news